These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 30081484)

  • 1. Recommendations for Improving the Quality of Rare Disease Registries.
    Kodra Y; Weinbach J; Posada-de-la-Paz M; Coi A; Lemonnier SL; van Enckevort D; Roos M; Jacobsen A; Cornet R; Ahmed SF; Bros-Facer V; Popa V; Van Meel M; Renault D; von Gizycki R; Santoro M; Landais P; Torreri P; Carta C; Mascalzoni D; Gainotti S; Lopez E; Ambrosini A; Müller H; Reis R; Bianchi F; Rubinstein YR; Lochmüller H; Taruscio D
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30081484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EuRRECa Project as a Model for Data Access and Governance Policies for Rare Disease Registries That Collect Clinical Outcomes.
    Ali SR; Bryce J; Tan LE; Hiort O; Pereira AM; van den Akker ELT; Appelman-Dijkstra NM; Bertherat J; Cools M; Dekkers OM; Kodra Y; Persani L; Smyth A; Smythe C; Taruscio D; Ahmed SF
    Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33255540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Quality Evaluation of Rare Disease Registries-An Assessment of the Essential Features of a Disease Registry.
    Ali SR; Bryce J; Kodra Y; Taruscio D; Persani L; Ahmed SF
    Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in mapping European rare disease databases, relevant for ML-based screening technologies in terms of organizational, FAIR and legal principles: scoping review.
    Raycheva R; Kostadinov K; Mitova E; Bogoeva N; Iskrov G; Stefanov G; Stefanov R
    Front Public Health; 2023; 11():1214766. PubMed ID: 37780450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RD-Connect Registry & Biobank Finder: a tool for sharing aggregated data and metadata among rare disease researchers.
    Gainotti S; Torreri P; Wang CM; Reihs R; Mueller H; Heslop E; Roos M; Badowska DM; de Paulis F; Kodra Y; Carta C; Martìn EL; Miller VR; Filocamo M; Mora M; Thompson M; Rubinstein Y; Posada de la Paz M; Monaco L; Lochmüller H; Taruscio D
    Eur J Hum Genet; 2018 May; 26(5):631-643. PubMed ID: 29396563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data Quality in Rare Diseases Registries.
    Kodra Y; Posada de la Paz M; Coi A; Santoro M; Bianchi F; Ahmed F; Rubinstein YR; Weinbach J; Taruscio D
    Adv Exp Med Biol; 2017; 1031():149-164. PubMed ID: 29214570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards FAIRification of sensitive and fragmented rare disease patient data: challenges and solutions in European reference network registries.
    Dos Santos Vieira B; Bernabé CH; Zhang S; Abaza H; Benis N; Cámara A; Cornet R; Le Cornec CMA; 't Hoen PAC; Schaefer F; van der Velde KJ; Swertz MA; Wilkinson MD; Jacobsen A; Roos M
    Orphanet J Rare Dis; 2022 Dec; 17(1):436. PubMed ID: 36517834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RD-Connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research.
    Thompson R; Johnston L; Taruscio D; Monaco L; Béroud C; Gut IG; Hansson MG; 't Hoen PB; Patrinos GP; Dawkins H; Ensini M; Zatloukal K; Koubi D; Heslop E; Paschall JE; Posada M; Robinson PN; Bushby K; Lochmüller H
    J Gen Intern Med; 2014 Aug; 29 Suppl 3(Suppl 3):S780-7. PubMed ID: 25029978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of the European Reference Network for Rare Bone Diseases (ERN BOND) and European Registries for Rare Bone and Mineral Conditions (EuRR-Bone) in the Governance of the Management of Rare Bone and Mineral Diseases.
    Priego Zurita AL; Boarini M; Casareto L; Cherenko M; Mordenti M; Moroni A; Ahmed SF; Appelman-Dijkstra NM; Sangiorgi L
    Calcif Tissue Int; 2024 Nov; 115(5):498-506. PubMed ID: 39060404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model for the European platform for rare disease registries.
    Vittozzi L; Gainotti S; Mollo E; Donati C; Taruscio D
    Public Health Genomics; 2013; 16(6):299-304. PubMed ID: 24503590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Landscape analysis of available European data sources amenable for machine learning and recommendations on usability for rare diseases screening.
    Raycheva R; Kostadinov K; Mitova E; Iskrov G; Stefanov G; Vakevainen M; Elomaa K; Man YS; Gross E; Zschüntzsch J; Röttger R; Stefanov R
    Orphanet J Rare Dis; 2024 Apr; 19(1):147. PubMed ID: 38582900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases.
    Mora M; Angelini C; Bignami F; Bodin AM; Crimi M; Di Donato JH; Felice A; Jaeger C; Karcagi V; LeCam Y; Lynn S; Meznaric M; Moggio M; Monaco L; Politano L; de la Paz MP; Saker S; Schneiderat P; Ensini M; Garavaglia B; Gurwitz D; Johnson D; Muntoni F; Puymirat J; Reza M; Voit T; Baldo C; Bricarelli FD; Goldwurm S; Merla G; Pegoraro E; Renieri A; Zatloukal K; Filocamo M; Lochmüller H
    Eur J Hum Genet; 2015 Sep; 23(9):1116-23. PubMed ID: 25537360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare Disease Registries Are Key to Evidence-Based Personalized Medicine: Highlighting the European Experience.
    Kölker S; Gleich F; Mütze U; Opladen T
    Front Endocrinol (Lausanne); 2022; 13():832063. PubMed ID: 35317224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge for a European network of biobanks for rare diseases taken up by RD-Connect.
    Monaco L; Crimi M; Wang CM
    Pathobiology; 2014; 81(5-6):231-236. PubMed ID: 25792211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current situation and needs of rare disease registries in Europe.
    Taruscio D; Gainotti S; Mollo E; Vittozzi L; Bianchi F; Ensini M; Posada M
    Public Health Genomics; 2013; 16(6):288-98. PubMed ID: 24503589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care.
    De Antonio M; Dogan C; Daidj F; Eymard B; Puymirat J; Mathieu J; Gagnon C; Katsahian S; ; Hamroun D; Bassez G
    Orphanet J Rare Dis; 2019 Jun; 14(1):122. PubMed ID: 31159885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National registries of rare diseases in Europe: an overview of the current situation and experiences.
    Taruscio D; Vittozzi L; Choquet R; Heimdal K; Iskrov G; Kodra Y; Landais P; Posada M; Stefanov R; Steinmueller C; Swinnen E; Van Oyen H
    Public Health Genomics; 2015; 18(1):20-5. PubMed ID: 25228300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scoping review of the recommendations and guidance for improving the quality of rare disease registries.
    Tarride JE; Okoh A; Aryal K; Prada C; Milinkovic D; Keepanasseril A; Iorio A
    Orphanet J Rare Dis; 2024 May; 19(1):187. PubMed ID: 38711103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.